Malat1 knockdown reduced cell apoptosis of mice cardiomyocytes under high glucose treatment by sponging miR-181a-5p, which may provide a novel target for diabetic cardiomyopathy [91]. Here, MALAT1 is linked to diabetic cardiomyopathy.